Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 5Stomatitis 3Head and Neck Neoplasms 3Fatigue 3Colorectal Neoplasms 3Pain 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Ulcer 1Trauma, Nervous System 1Spondylitis, Ankylosing 1Skin Neoplasms 1Schwannomatosis 1Rectal Neoplasms 1Psoriasis 1Pleural Effusion, Malignant 1Pancreatic Cyst 1Ovarian Neoplasms 1Non-functioning Pituitary Adenoma 1Neurofibromatosis 1 1Neurilemmoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Malignant Neoplasm of Colorectum 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Saline Solution 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Non-functioning Pituitary Adenoma × Saline Solution × Clear all
NCT05005715 2021-08-13

Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery

Seoul National University Hospital

Phase 2 Unknown
64 enrolled
Endocrine

Non-functioning Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡